TORCH syndrome

Summary

TORCH syndrome (MONDO:0043275) is a disease. A subtype of post-infectious syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	TORCH syndrome
Mondo ID	MONDO:0043275
DOID	DOID:0080835
NCIT	C98609
SNOMED CT	41679006
UMLS	C0270173
MedGen	78715
Is cancer (heuristic)	no

Also known as: TORCH infection · TORCH syndrome · torch syndrome · toxoplasmosis, Other infections, Rubella, Cytomegalovirus, and Herpes simplex Virus (TORCH) syndrome

Disease family

Classification path: disease › human disease › disease by body system or component › syndromic disease › post-infectious syndrome › TORCH syndrome

Related subtypes (2): Zika virus congenital syndrome, KSHV inflammatory cytokine syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.